RESEARCH TRIANGLE PARK, NC, March 1st, 2016 – National Institute of Allergies and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) awarded NIRvana Sciences a Phase II grant to further develop its bacteriochlorin dyes for use in flow cytometry applications.

RESEARCH TRIANGLE PARK, NC, September 15, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that in addition to its protein conjugation lab, it has also set-up a dye synthesis lab and hired another chemist, Chih-Yuan Chen, to its team.

RESEARCH TRIANGLE PARK, NC, May 18th, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has been awarded a $50k Phase I STTR Matching Grant from the One North Carolina Small Business Program supported by NC Department of Commerce’s Office of Science, Technology and Innovation.

RESEARCH TRIANGLE PARK, NC, September 1st, 2015 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that it has successfully closed its Series A investment round. The oversubscribed round includes investments from many angel investments groups in North Carolina and South Carolina as well as some private angels.

RESEARCH TRIANGLE PARK, NC, June, 2014 – NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins and chlorins in the field of fluorescent dyes, announced that Rich West has joined the Board of Directors. Rich is CEO of Baebies and brings significant executive experience from his previous successful exit of Advanced Liquid Logic to Illumina in 2013.

RESEARCH TRIANGLE PARK, NC, May 23rd, 2014– NIRvana Sciences, Inc., the leading developer of synthetic bacteriochlorins in the field of fluorescent dyes, today announced that industry scientist, Bruce Pitner, has joined its executive team as Chief Scientific Officer. DOWNLOAD PDF